NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

51 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q1 2024.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12,194,479 shares of 264,351,875 outstanding shares and own 4.61% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (6,909,220 shares), Caligan Partners LP (756,538 shares), TWO SIGMA ADVISERS, LP (617,100 shares), TWO SIGMA INVESTMENTS, LP (575,580 shares), Temasek Holdings (Private) Ltd (566,650 shares), GSA CAPITAL PARTNERS LLP (432,621 shares), BOOTHBAY FUND MANAGEMENT, LLC (378,269 shares), Exome Asset Management LLC (325,762 shares), EDBI Pte Ltd (222,136 shares), and abrdn plc (162,580 shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.